- Home
- CYH vs ALMS Comparison
CYH vs ALMS Comparison
Compare CYH & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- ALMS
- Stock Information
- Founded
- CYH 1985
- ALMS 2021
- Country
- CYH United States
- ALMS United States
- Employees
- CYH N/A
- ALMS N/A
- Industry
- CYH Hospital/Nursing Management
- ALMS
- Sector
- CYH Health Care
- ALMS
- Exchange
- CYH Nasdaq
- ALMS NYSE
- Market Cap
- CYH 623.8M
- ALMS 652.3M
- IPO Year
- CYH 1991
- ALMS 2024
- Fundamental
- Price
- CYH $3.74
- ALMS $9.44
- Analyst Decision
- CYH Hold
- ALMS Strong Buy
- Analyst Count
- CYH 5
- ALMS 6
- Target Price
- CYH $5.20
- ALMS $29.60
- AVG Volume (30 Days)
- CYH 2.0M
- ALMS 90.9K
- Earning Date
- CYH 10-23-2024
- ALMS 11-13-2024
- Dividend Yield
- CYH N/A
- ALMS N/A
- EPS Growth
- CYH N/A
- ALMS N/A
- EPS
- CYH N/A
- ALMS N/A
- Revenue
- CYH $12,551,000,000.00
- ALMS N/A
- Revenue This Year
- CYH $1.19
- ALMS N/A
- Revenue Next Year
- CYH $1.48
- ALMS N/A
- P/E Ratio
- CYH N/A
- ALMS N/A
- Revenue Growth
- CYH 0.81
- ALMS N/A
- 52 Week Low
- CYH $2.31
- ALMS $8.23
- 52 Week High
- CYH $6.29
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- CYH 31.56
- ALMS N/A
- Support Level
- CYH $3.61
- ALMS N/A
- Resistance Level
- CYH $3.85
- ALMS N/A
- Average True Range (ATR)
- CYH 0.24
- ALMS 0.00
- MACD
- CYH -0.02
- ALMS 0.00
- Stochastic Oscillator
- CYH 20.61
- ALMS 0.00
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.